15277 Malignancy rates and comparisons to the general US population through 3 years of follow-up in guselkumab-treated patients with moderate to severe psoriasis from the VOYAGE 1 and 2 trials
Papp, Kim A., Reich, Kristian, Gordon, Ken B., Kimball, Alexa B., Ramachandran, Paraneedharan, Blauvelt, Andrew, Lebwohl, Mark, Song, Michael, Ramachandran, Paraneedharan, Randazzo, Bruce, Shen, YaungVolume:
83
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.06.667
Date:
December, 2020
File:
PDF, 1.21 MB
2020